Universidad de Caldas, Health Research Institute, Basic Clinical Department - Manizales, Colombia.
Universidad de Caldas, Health Research Institute, Research group on Health Promotion and Disease Prevention - Manizales, Colombia.
Rev Bras Epidemiol. 2023 Sep 18;26:e230040. doi: 10.1590/1980-549720230040. eCollection 2023.
To determine 5-year survival in patients with colorectal cancer (CRC) according to patient and tumor characteristics.
Longitudinal study based on incident cases of invasive CRC between 2008 and 2017 captured by the Manizales Population-based Cancer Registry (n=850). Patients were followed up to August 24th, 2021. Cause-specific survival and net survival were calculated for sociodemographic and tumor characteristics, and Cox multivariate was fitted.
Fifty-five percent of cases occurred in women. The most frequent histological type was adenocarcinoma (78.2%). The most frequent locations were rectum (32.0%), ascending colon (16.6%), and sigmoid (16.2%). Twenty-five percent of cases were diagnosed in stage IV. There were 567 deaths due to CRC. The 5-year specific survival was 45.8% (95%CI 42.4-49.3), with independent effects for age (HR=1.83; 95%CI 1.26-2.65 age >75 years vs. <50 years) and advanced clinical stage (HR=2.5 and HR 5.7 for stages III and IV vs. stage I, respectively). Lower survival was observed in patients of medium socioeconomic status compared with higher socioeconomic status (HR=1.52; 95%CI 1.08-2.14), but not in patients of low socioeconomic status. No independent effects were observed for the health insurance regime.
In Manizales, approximately 5 out of 10 patients with invasive CRC die in the first five years after diagnosis, with a lower survival in patients older than 75 years, from medium socioeconomic level and diagnosed in advanced clinical stages.
根据患者和肿瘤特征,确定结直肠癌(CRC)患者的 5 年生存率。
本研究基于 2008 年至 2017 年间曼尼萨莱斯人群癌症登记处(n=850)中侵袭性 CRC 的发病病例进行的纵向研究。对患者进行随访,截至 2021 年 8 月 24 日。根据社会人口统计学和肿瘤特征计算特定原因生存和净生存,并拟合 Cox 多变量。
55%的病例发生在女性中。最常见的组织学类型是腺癌(78.2%)。最常见的部位是直肠(32.0%)、升结肠(16.6%)和乙状结肠(16.2%)。25%的病例诊断为 IV 期。共有 567 例 CRC 死亡。5 年特异性生存率为 45.8%(95%CI 42.4-49.3),年龄(HR=1.83;95%CI 1.26-2.65,年龄>75 岁与<50 岁)和临床晚期(HR=2.5 和 HR 5.7,III 期和 IV 期与 I 期相比)有独立影响。与高社会经济地位相比,中社会经济地位的患者生存率较低(HR=1.52;95%CI 1.08-2.14),但低社会经济地位的患者则不然。医疗保险制度没有独立影响。
在马尼萨莱斯,大约每 10 名侵袭性 CRC 患者中有 5 名在诊断后五年内死亡,年龄>75 岁、中社会经济水平和诊断为晚期临床阶段的患者生存率较低。